ScholarIQanswers from OpenAlex
Bimekizumab versus Secukinumab in Plaque Psoriasis
PaperCitations, authors & open-access status
Bimekizumab versus Secukinumab in Plaque Psoriasis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Bimekizumab versus Secukinumab in Plaque Psoriasis have?
ScholarIQcitation count
Bimekizumab versus Secukinumab in Plaque Psoriasis has 411 citations in the OpenAlex counts ScholarIQ stores.
When was Bimekizumab versus Secukinumab in Plaque Psoriasis published?
ScholarIQyear
Bimekizumab versus Secukinumab in Plaque Psoriasis has 2021 year in the ScholarIQ index.
What is the open-access status of Bimekizumab versus Secukinumab in Plaque Psoriasis?
ScholarIQoa status
Bimekizumab versus Secukinumab in Plaque Psoriasis has closed oa status in the ScholarIQ index.
What is the DOI of Bimekizumab versus Secukinumab in Plaque Psoriasis?
ScholarIQdoi
The DOI for Bimekizumab versus Secukinumab in Plaque Psoriasis is on the source record.
What is the PMID of Bimekizumab versus Secukinumab in Plaque Psoriasis?
ScholarIQpmid
The PMID for Bimekizumab versus Secukinumab in Plaque Psoriasis is on the source record.
What is the OpenAlex record for Bimekizumab versus Secukinumab in Plaque Psoriasis?
ScholarIQopenalex
The OpenAlex for Bimekizumab versus Secukinumab in Plaque Psoriasis is on the source record.